CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
Ultrasound and biyopsyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05927727
NCT05927727N/ACompleted

Benign-Malign Differentiation Of Axillary Lymph Nodes: The Role Of Superb Microvascular Imaging

Ankara Education and Research Hospital·interventional·Posted Jul 3, 2023·Updated Jul 3, 2023

In Brief

A clinical study evaluating Ultrasound and biyopsy for Diagnosis and Axilla; Breast. Completed, enrolled 102 participants across 1 site.

Detailed Summary

102 patients who have suspicious ALNs were included in our prospective study, which was approved by a tertiary health care facility ethics committee. Each suspicious lymph nodes (LNs) were examined with PDUS and SMI in terms of distribution, appearance and number of vascular structures and the still images were stored. Subsequently, imaging findings were re-evaluated after histopathological or follow-up results and were compared between benign and malign groups. In addition, we revealed the diagnostic perfomance of using the each possible combination of these features in PDUS and SMI. Finally, two radiologists with 22 years and 4 years of experience analyzed the images and interobserver agreement was assessed

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 3, 2023
Enrollment StartApr 1, 2021
Primary CompletionApr 1, 2022
Study CompletionMay 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 3.0 years ago

Interventions

Ultrasound and biyopsyother

Each participant has undergone to ultrasound and biopsy procedure if they have suspicious lymph node in axillar region